LDLRAD4
Low-density lipoprotein receptor class A domain-containing protein 4
Also known as: C18orf1, LRAD4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15165
- Gene
- LDLRAD4
- Ensembl
- ENSG00000168675
- Chromosome
- 18
- Canonical length
- 306 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables R-SMAD binding activity. Involved in negative regulation of cell migration; negative regulation of epithelial to mesenchymal transition; and negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway. Located in early endosome membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
306 residues, UniProt reviewed canonical sequence.
>O15165|LDLRAD4
1 MPEAGFQATN AFTECKFTCT SGKCLYLGSL VCNQQNDCGD NSDEENCLLV TEHPPPGIFN
61 SELEFAQIII IVVVVTVMVV VIVCLLNHYK VSTRSFINRP NQSRRREDGL PQEGCLWPSD
121 SAAPRLGASE IMHAPRSRDR FTAPSFIQRD RFSRFQPTYP YVQHEIDLPP TISLSDGEEP
181 PPYQGPCTLQ LRDPEQQMEL NRESVRAPPN RTIFDSDLID IAMYSGGPCP PSSNSGISAS
241 TCSSNGRMEG PPPTYSEVMG HHPGASFLHH QRSNAHRGSR LQFQQNNAES TIVPIKGKDR
301 KPGNLVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LDLRAD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 56 nTPM
- thymus: 42 nTPM
- midbrain: 36 nTPM
- basal ganglia: 31 nTPM
- hippocampal formation: 27 nTPM
- heart muscle: 20 nTPM
Single-cell type
- choroid plexus epithelial cells: 2,113 nCPM
- microglia: 1,784 nCPM
- cone photoreceptor cells: 1,706 nCPM
- thymocytes: 1,652 nCPM
- prostatic glandular cells: 1,046 nCPM
- somatotrophs: 995 nCPM
Immune cell
- basophil: 13 nTPM
- neutrophil: 12 nTPM
- NK-cell: 9.1 nTPM
- non-classical monocyte: 8.5 nTPM
- naive CD4 T-cell: 8.1 nTPM
- intermediate monocyte: 7.7 nTPM
Brain region
- medulla oblongata: 153 nTPM
- thalamus: 149 nTPM
- choroid plexus: 131 nTPM
- pons: 129 nTPM
- basal ganglia: 128 nTPM
- white matter: 127 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.62
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell migration
- negative regulation of epithelial to mesenchymal transition
- negative regulation of SMAD protein signal transduction
- negative regulation of transforming growth factor beta receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LDLRAD4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LDLRAD4 as an antibody target. Whether an autoantibody or antibody against LDLRAD4 could matter depends on whether native LDLRAD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LDLRAD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LDLRAD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...